ERBB2 and breast cancer: Differences among the breast cancer subtypes could also be detected in the evaluation of the BM patterns: HER2-positive patients had more often BMs in the posterior fossa (58% versus 49%; P < 0.001) and less often leptomeningeal disease (9% versus 19%; P < 0.001).